Frailty and patient centered outcomes in candidates for lung transplantation
Frailty and patient centered outcomes in candidates for lung transplantation
批准号:
10191001
负责人:
Jonathan Paul Singer
金额:
$69.47万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2023-06-30
关键词:
AbdomenAchievementAddressAdultAgeAgingAllograftingAmericanAreaAutomobile DrivingBenefits and RisksBiological MarkersBody CompositionCachexiaCategoriesCessation of lifeClinicalClinical TrialsCommunitiesCountryDataDecision MakingDevelopmentDiseaseElderlyFunctional disorderFutureGeriatricsGuidelinesIndividualInfrastructureKnowledgeLungLung TransplantationLung diseasesMeasurementMeasuresMediatingMedicalModelingMulticenter StudiesNIH Program AnnouncementsNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesOperative Surgical ProceduresOrgan TransplantationOutcomeOutcome StudyPathway interactionsPatient-Focused OutcomesPatientsPennsylvaniaPerformancePerioperative complicationPhenotypePhysical PerformancePhysiologicalPoliciesPopulationProspective StudiesProspective cohort studyResearchResourcesRiskRisk FactorsSan FranciscoSocietiesSolidSumSyndromeTherapeutic InterventionTransplant RecipientsTransplantationUniversitiesValidity of ResultsWaiting Listsclinical biomarkerscostdesigndisabilitydisability riskevidence basefitnessfrailtygraft functionhealth related quality of lifehuman old age (65+)improvedindexinginstrumentmortalitymortality risknovelorgan allocationpost-transplantpredictive modelingprogramsprospectiveprotein biomarkersrisk stratificationsarcopeniastressorsurvival outcomesurvival predictionsystemic inflammatory responsetooltransplant centerstreatment responsetrend
中文摘要
项目摘要/总结
对于患有终末期肺部疾病的成年人,肺移植旨在延长生存期,缓解
改善与健康相关的生活质量(HRQL)。2005年对器官分配政策进行了全面改革
在不影响一年生存率的情况下,优先为病情较重和老年人进行肺移植-主要措施
移植的功效。然而,这一改革付出了巨大的代价,包括最近的趋势,
残疾增加,HRQL较差,长期死亡率增加。迫切需要区别对待
候选人可能在手术后生存,残疾和HRQL得到改善,并确定新的信息性预
移植因素以帮助候选人决策。最近,我们发现脆弱是普遍的,
与残疾有关。与其他实体器官移植人群相比,只有两个公认的
虚弱程度的测量可预测肺移植候选人的等待名单死亡/除名风险。此外,我们的早期
数据表明,虚弱的既定措施可能会受到肺部疾病的干扰,导致
分类错误我们还表明,代表假定的脆弱途径的蛋白质生物标志物(即,系统性
炎症、老化和恶病质)在肺移植候选者中是重要的。是否导致
虚弱在异质性肺部疾病中是普遍的,或者虚弱的亚表型(所谓的
具有不同病理生物学、结果风险和治疗反应的内型(endotypes)是未知的。在此我们
我建议在美国三个大型肺移植中心进行一项前瞻性队列研究,以解决三个基本问题,
脆弱性可能为肺移植领域提供信息的新领域。在624名肺移植候选人中,我们将
评估现有的脆弱性指标以及性能、生物标志物和拟人化指标(包括
肌肉减少症)与肺部疾病相关。在这些候选人中,480人最终将接受移植,
我们将评估移植后一年的存活率、残疾率和HRQL。在目标1中,我们将使用
肺疾病相关的脆弱领域的措施,以设计一种新的脆弱指数肺移植。我们
假设该指数将比现有措施更好地量化脆弱归因于压力的脆弱性
在社区居住的老年人群体中发展。在目标2中,我们将利用潜在类别分析(LCA)
确定脆弱的内在型。我们假设LCA考虑了临床和生物标志物指标,
驱动虚弱的机制将识别肺病中不同的内型。在目标3中,我们将开发一种临床
预测模型,以确定那些在肺移植后残疾,HRQL差和死亡的风险。我们假设
包括虚弱的模型将比不包括虚弱的模型更好地预测具有改善的残疾和HRQL的存活率。
总之,这一建议将产生一种新的测量接受肺移植的成人相关虚弱的方法,
可能,那些患有肺部疾病的人正在接受其他大手术;将为他们提供新的知识。
最后,通过考虑生存率和以患者为中心的结局,
产生一个预测模型,将立即帮助知情决策的方式,目前是不可能的。
英文摘要
PROJECT ABSTRACT/SUMMARY
For adults suffering from from end-stage lung disease, lung transplantation aims to extend survival, relieve
disability, and improve health-related quality of life (HRQL). An overhaul in organ allocation policy in 2005
prioritized lung transplant for sicker and older adults without impacting one-year survival – the primary measure
of transplant efficacy. This overhaul has come at substantial cost, however, including recent trends towards
increased disability, poorer HRQL, and increased longer-term mortality. There is an urgent need to discriminate
candidates likely to survive after surgery with improved disability and HRQL and to identify new informative pre-
transplant factors to aid in candidacy decision-making. Recently, we found that frailty was prevalent and
associated with disability. In contrast to other solid organ transplant populations, only one of two well-established
measures of frailty predicted risk of waitlist death/delisting in lung transplant candidates. Additionally, our early
data suggests that established measures of frailty may be confounded by lung disease, resulting in
misclassification. We also showed that protein biomarkers representing putative pathways of frailty (i.e., systemic
inflammation, aging, and cachexia) are important in lung transplant candidates. Whether the pathways causing
frailty are universal across heterogeneous lung diseases or whether sub-phenotypes of frailty (so called
“endotypes”) with distinct pathobiology, outcome risks, and treatment responses exist are unknown. Herein, we
propose a prospective cohort study in three large U.S. lung transplant centers to address three fundamental and
new areas in which frailty may inform the field of lung transplantation. In 624 lung transplant candidates, we will
assess existing frailty measures as well as performance, biomarker, and anthropomorphic measures (including
sarcopenia) relevant in lung disease. Of these candidates, 480 will ultimately undergo transplantation in whom
we will evaluate survival, disability, and HRQL one year after transplant. In Aim 1, we will use operational
measures of frailty domains relevant in lung disease to design a novel frailty index for lung transplantation. We
hypothesize that this index will better quantify frailty-attributable vulnerability to stressors than existing measures
developed in community-dwelling older adult populations. In Aim 2, we will utilize latent class analysis (LCA) to
identify endotypes of frailty. We hypothesize that LCA that considers clinical and biomarker measures of
mechanisms driving frailty will identify distinct endotypes in lung disease. In Aim 3, we will develop a clinical
prediction model to identify those at risk for disability, poor HRQL, and death after lung transplant. We hypothesize
that a model that includes frailty will better predict survival with improved disability and HRQL than a model without.
In sum, this proposal will yield a novel measure of frailty relevant for adults undergoing lung transplantation and,
possibly, those with lung disease undergoing other major surgeries; will provide new knowledge into the
pathobiology of frailty in lung disease; and, finally, by considering survival and patient-centered outcomes, will
yield a prediction model that will immediately aid informed decision making in a way that is not presently possible.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.healun.2019.03.006
发表时间:
2019-07
期刊:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
影响因子:
--
作者:
[A. Venado;C. McCulloch;J. Greenland;P. Katz;A. Soong;Pavan Shrestha;S. Hays;J. Golden;R. Shah;L. Leard;M. Kleinhenz;J. Kukreja;L. Zablotska;I. Allen;K. Covinsky;P. Blanc;J. Singer]
通讯作者:
A. Venado;C. McCulloch;J. Greenland;P. Katz;A. Soong;Pavan Shrestha;S. Hays;J. Golden;R. Shah;L. Leard;M. Kleinhenz;J. Kukreja;L. Zablotska;I. Allen;K. Covinsky;P. Blanc;J. Singer
A nonlinear relationship between visceral adipose tissue and frailty in adult lung transplant candidates.
成人肺移植候选物中内脏脂肪组织与脆弱的非线性关系。
DOI:
10.1111/ajt.15525
发表时间:
2019-11
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Anderson MR, Kolaitis NA, Gao Y, Kukreja J, Greenland J, Hays S, Wolters P, Golden J, Diamond J, Palmer S, Arcasoy S, Udupa J, Christie JD, Lederer DJ, Singer JP]
通讯作者:
Singer JP
DOI:
10.1164/rccm.207i11p5
发表时间:
2023-06-01
期刊:
American journal of respiratory and critical care medicine
影响因子:
24.7
作者:
[]
通讯作者:
DOI:
10.1513/annalsats.202302-129st
发表时间:
2023-06
期刊:
Annals of the American Thoracic Society
影响因子:
8.3
作者:
[]
通讯作者:
Current Beliefs and Practices Regarding the Management of Obesity in Patients with Progressive Interstitial Lung Disease.
当前关于进行性间质性肺病患者肥胖管理的信念和实践。
DOI:
10.1513/annalsats.202201-019rl
发表时间:
2022
期刊:
Annals of the American Thoracic Society
影响因子:
8.3
作者:
[Anderson,MichaelaR, Aronson,KerriI, Diamond,JoshuaM, Christie,JasonD, Singer,JonathanP]
通讯作者:
Singer,JonathanP
共 7 条
The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation.
-
批准号:10677598
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2022
-
负责人:Jonathan Paul Singer
-
依托单位:
The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation.
-
批准号:10429878
-
项目类别:
-
资助金额:$45.79万
-
财政年份:2022
-
负责人:Jonathan Paul Singer
-
依托单位:
The Effects of Lung Transplant on Disability and Health-Related Quality of Life
-
批准号:8534269
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2012
-
负责人:Jonathan Paul Singer
-
依托单位:
The Effects of Lung Transplant on Disability and Health-Related Quality of Life
-
批准号:8374331
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2012
-
负责人:Jonathan Paul Singer
-
依托单位:
The Effects of Lung Transplant on Disability and Health-Related Quality of Life
-
批准号:9114646
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2012
-
负责人:Jonathan Paul Singer
-
依托单位:
The Effects of Lung Transplant on Disability and Health-Related Quality of Life
-
批准号:8703763
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2012
-
负责人:Jonathan Paul Singer
-
依托单位:
The effects of lung transplantation on lung disease related disabilities
-
批准号:8057964
-
项目类别:
-
资助金额:$6.33万
-
财政年份:2011
-
负责人:Jonathan Paul Singer
-
依托单位:
海外基金